Last Updated On 6/10/2025 6:33:58 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Adverum |
Recipient: An Immediate Family Member |
Company: Neurogene |
Recipient: An Immediate Family Member |
Company: Genentech/Roche |
Recipient: An Immediate Family Member |
Company: Regeneron |
Recipient: An Immediate Family Member |
Company: Outlook Therapeutics |
Recipient: An Immediate Family Member |
Company: Optos Plc |
Recipient: An Immediate Family Member |
Company: Novartis |
Recipient: An Immediate Family Member |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property |
Please describe: Intellectual property rights (SOPHiA Genetics)
|
Recipient: Your Institution |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
Company: UpToDate, Section Editor |
Recipient: You |
Company: JCO Precision Oncology, Associate Editor |
Recipient: You |
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|